Stock Information
Novavax Inc (NVAX)
Ticker Symbol: NVAX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,647.74 mil
Piotroski score: 6
PE Ratio: 4.527
EPS (TTM): 1.7689
Revenue (TTM): $6.56 M
Dividend Yield: N/A%
ROE: 283.08%
Latest News
-
Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Tue, Mar 3, 2026 4:22 PM
-
Novavax, Inc. 2025 Q4 - Results - Earnings Call Presentation
Sat, Feb 28, 2026 6:08 PM
-
What's Going On With Novavax Stock On Friday?
Fri, Feb 27, 2026 3:20 PM
-
Novavax: The Bear Case Is Broken, But The Bull Case Needs More Proof
Fri, Feb 27, 2026 12:11 PM
-
HC Wainwright & Co. Maintains Buy on Novavax, Raises Price Target to $16
Fri, Feb 27, 2026 7:40 AM
-
COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb
Thu, Feb 26, 2026 3:19 PM
-
Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript
Thu, Feb 26, 2026 3:08 PM
-
Novavax shares are trading higher. The company reported Q4 financial results.
Thu, Feb 26, 2026 11:11 AM
-
Novavax Sees FY2026 Sales $230.000M-$270.000M vs $381.222M Est
Thu, Feb 26, 2026 9:06 AM
-
Novavax Earnings Review: Q4 Summary
Thu, Feb 26, 2026 9:06 AM
Key Financials
Financial data not available